Provectus Biopharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of PVCT for the last quarter is 121.11 k USD, and it's 73.68% higher compared to the previous quarter. The net income of Q4 23 is -663.41 k USD.